Skip to main content

Jornay PM

Generic name: methylphenidate hydrochloride
Dosage form: oral extended-release capsule
Drug class: CNS stimulants

Medically reviewed by Philip Thornton, DipPharm. Last updated on Aug 23, 2023.

What is Jornay PM?

Jornay PM is a once-a-day capsule used to treat attention deficit hyperactivity disorder (ADHD). It contains a central nervous system (CNS) stimulant called methylphenidate hydrochloride.

It's not known exactly how Jornay PM works in people with ADHD, but it is a stimulant that increases activity in the brain, especially in the areas that help regulate behavior and attention. It helps to boost the levels of dopamine and noradrenaline, which are chemical messengers (neurotransmitters), by preventing their re-uptake from the space between nerve cells (neurons) in the brain. Low levels of these chemical messengers have been found in people with ADHD.

Jornay PM is taken in the evening. Each capsule contains two layers. The outside layer is designed to delay the release of the drug so that it doesn't start to be released until about 12 hours after it is taken. The inside layer extends the amount of time the drug is released into your body for. The two-layer approach is designed to help ensure Jornay PM is working when you wake up and keeps working during the day.

Medications containing methylphenidate, such as Jornay PM, are schedule II federally controlled substances because they can be a target for people who abuse prescription medicines or street drugs. Selling or giving away Jornay PM may harm others, and is against the law.

Jornay PM was approved for use by the US Food and Drug Administration (FDA) in 2018, although methylphenidate in another formulation was first approved many years earlier in 1955.

What is Jornay PM used for?

Jornay PM is a prescription medicine used for the treatment of ADHD in people 6 years of age and older. It may help increase attention and decrease impulsiveness and hyperactivity in people 6 years of age and older with ADHD.

It is not known if it is safe and effective in children under 6 years of age.

Important information

Jornay PM can cause serious side effects, including:

Who should not take Jornay PM?

Do not take Jornay PM if you or your child is:

What should I tell my doctor before taking Jornay PM?

Before taking Jornay PM, tell your or your child's healthcare provider about all medical conditions, including if you or your child:

How should I take Jornay PM?

What happens if I miss a dose?

If a dose of Jornay PM is missed, it should be taken as soon as you remember the same evening. If you do not remember until the next morning you should not take the dose. Wait until that evening to take the next scheduled dose. A missed dose should not be taken in the morning.

What happens if I overdose?

If you or your child takes too much Jornay PM, call your healthcare provider or go to the nearest hospital emergency room right away.

What should I avoid while taking Jornay PM?

Avoid drinking alcohol during treatment with Jornay PM. This may cause a faster release of the medicine.

Dosing information

The recommended starting dose of Jornay PM for patients 6 years and over is 20 mg daily in the evening. The dose may be increased weekly in increments of 20 mg up to a maximum daily dose of 100 mg. Jornay PM should be taken between 6:30 pm and 9:30 pm. The timing of the dose can be adjusted within this window to help reduce side effects and ensure it is working when needed the following day.

See the Full Prescribing Information for further details about Jornay PM dosing.

What are the side effects of Jornay PM?

Jornay PM can cause serious side effects, including:

The most common side effects of methylphenidate products in children, adolescents, and adults with ADHD include:

The most common side effects of Jornay PM, in children age 6 to 12 with ADHD include:

These are not all the possible side effects of this medication.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Tell your healthcare provider about all of the medicines that you or your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Jornay PM and some medicines may interact with each other and cause serious side effects. Sometimes the doses of other medicines will need to be adjusted during treatment.

Your healthcare provider will decide whether Jornay PM can be taken with other medicines.

Especially tell your healthcare provider if you or your child takes medicine to treat depression, including MAOIs.

Know the medicines that you or your child takes. Keep a list of the medicines with you to show your healthcare provider and pharmacist when you or your child get a new medicine.

Do not start any new medicine during treatment without talking to your or your child's healthcare provider first.

Pregnancy and breastfeeding

Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known whether Jornay PM will harm your unborn baby.

There is a pregnancy registry for females who are exposed to this medication during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Jornay PM and their baby. If you or your child becomes pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychostimulants. You can register by calling 1-866-961-2388.

Tell your healthcare provider if you are breastfeeding or plan to breastfeed. Jornay PM passes into breast milk. Talk to your healthcare provider about the best way to feed the baby during treatment with this medication.


Keep out of the reach of children.

What are the ingredients in Jornay PM?

Active Ingredient: methylphenidate hydrochloride

Inactive Ingredients: dibutyl sebacate, diglycerides, ethylcellulose, hydroxypropyl cellulose, hypromellose, magnesium stearate, methacrylic acid copolymer Type B, microcrystalline cellulose, monoglycerides, polysorbate 80, and talc.

The capsule shell of 20 and 40 mg strength capsules contains FD&C Blue #1, hypromellose, titanium dioxide, yellow iron oxide, and black ink for the imprint.

The capsule shell of 60 and 80 mg strength capsules contains FD&C Blue #1, hypromellose, titanium dioxide, and black ink for the imprint. The capsule shell of 100 mg strength capsule contains black iron oxide, FD&C Blue#1, hypromellose, red iron oxide, titanium dioxide, black ink, and white ink for the imprint.

Jornay PM is manufactured for Ironshore Pharmaceuticals Inc.

Popular FAQ

Metilfenidato is the Spanish, Italian, and Portuguese translation for methylphenidate which may be used to treat children or adults with attention deficit hyperactivity disorder (ADHD) to help with hyperactivity and impulsive behavior, and allow them to concentrate better. Metilfenidato may also be used to treat adults with narcolepsy. Metilfenidato translates to methylphenidate. Continue reading

More FAQ

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.